missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human TAFA5/FAM19A5 ELISA Kit
Click to view available options
Quantity:
5 x 96 Tests
96 Tests
Unit Size:
Each
Pack of 96
Description
Human TAFA5/FAM19A5 quantitates human TAFA5/FAM19A5 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human TAFA5/FAM19A5.
Acts as a chemokine-like protein by regulating cell proliferation and migration through activation of G protein-coupled receptors (GPCRs), such as S1PR2 and FPR2. Stimulates chemotactic migration of macrophages mediated by the MAPK3/ERK1 and AKT1 pathway. Blocks TNFSF11/RANKL-induced osteoclast formation from macrophages by inhibiting up-regulation of osteoclast fusogenic and differentiation genes. Stimulation of macrophage migration and inhibition of osteoclast formation is mediated via GPCR FPR2. Acts as an adipokine by negatively regulating vascular smooth muscle cell (VSMC) proliferation and migration in response to platelet-derived growth factor stimulation via GPCR S1PR2 and G protein GNA12/GNA13-transmitted RHOA signaling . Inhibits injury-induced cell proliferation and neointima formation in the femoral arteries
Specifications
Specifications
| Accession Number | Chemokine-like protein TAFA-5; Fam19a5; family with sequence similarity 19 (chemokine (C-C motif)-like), member A5; family with sequence similarity 19 member A5, C-C motif chemokine like; family with sequence similarity 19, member A5; protein FAM19A5; QLLK5208; RGD1562115; TAFA protein 5; TAFA5; Tafa-5; Tara-5; UNQ5208; UNQ5208/PRO34524 |
| Assay Range | 15 to 4,000 pg/mL |
| Assay Sensitivity | 15 pg/mL |
| Conjugate | HRP |
| Product Type | ELISA |
| Sample Type | Plasma, Serum, Supernatant |
| For Use With (Equipment) | Colorimetric Microplate Reader |
| Gene ID (Entrez) | 25817 |
| Gene Symbol | TAFA5 |
| Interassay CV | <12% |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction